期刊文献+

某综合医院多重耐药菌社区发生感染的现状调查 被引量:29

Community-onset multi-drug resistant organism infections in a general hospital
下载PDF
导出
摘要 目的了解多重耐药菌(MDROs)社区发生感染(COI)的特点。方法对某综合医院2008年7月1日—2010年6月30日所有金黄色葡萄球菌、肠球菌属、大肠埃希菌、肺炎克雷伯菌和鲍曼不动杆菌培养阳性的患者进行前瞻性调查,了解MDRO-COIs情况。结果调查期间的住院患者中发生金黄色葡萄球菌、肠球菌属、鲍曼不动杆菌、大肠埃希菌和肺炎克雷伯菌感染共1 646例次,包括COIs 1 148例次,其中MDROs感染470例次,占40.94%;医院发生感染(HOI)498例次,其中MDROs感染260例次,占52.21%,显著高于MDRO-COIs的比例,差异有统计学意义(χ2=17.87,P=0.00)。MDRO-COIs病原体标本主要来源于痰或气管分泌物(36.38%,171/470),其次为尿液(35.32%,166/470),两者共占71.70%。在科室分布中,MDRO-COIs比例以重症监护室最高,达64.75%。在各COI感染部位中,呼吸系统MDROs感染比例最高,达60.71%。结论 MDRO-COIs情况严重,应加强对此类患者的管理,预防MDROs在医院内的传播。 Objective To realize lhe characterislics of community-onset multi-drug resistant organism infections (MDR(YCOIs). Methods A prospective investigation was conducted on patients with positive culture of Staphylo- coccus aureus , Enterococcus, Escherichia coli , Klebsiella pneumoniae , and Acinetobacter baumannii between July 1, 2008 and June 30,2010. Results A total of 1 646 episodes of Staphylococcus aureus, Enterococcus, Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae infections occurred, 1 148 of which were COIs, including 470 (40. 94%) MDRO infeelions ; 498 of which were hospital-onset (HO) infections , including 260 (52. 21 %) MDRO infections, which was significantly higher than that of MDRO-COI rate (Z2 = 17.87, P = 0. 00). MDRO- COI pathogens were mainly from sputum or bronchial secretion (1 71/470, 36. 38 %), the next was urine( 166/470, 35.32%), these samples accounted for 71.70% of all. Of all departments, MDRO-COI rate was the highest in in- tensive care unil (ICU) (64. 75G). For lhe infection sites of COIs, respiratory MDRO infection was the highest (60. 71 %). Conclusion MDRO-COls are serious, the management of patients with MDRO-COIs should be en- hanced, transmission in the hospital should be avoided.
出处 《中国感染控制杂志》 CAS 2012年第1期21-24,共4页 Chinese Journal of Infection Control
关键词 多重耐药菌 社区发生感染 医院发生感染 抗药性 微生物 合理用药 multi-drug resislant organisms community onset infection hospital-onset infection drug resistance,microbial rational use of drug
  • 相关文献

参考文献10

  • 1中华人民共和国卫生部.卫生部办公厅关于加强多重耐药菌医院感染控制工作的通知[S].北京,2008.
  • 2Murray R J,Lim T T,Pearson J C,et al.Community-onset me-thicillin-resistant Staphylococcus aureus bacteremia in NorthernAustralia[J].Int J Infect Dis,2004,8(5):275-283.
  • 3.医院感染诊断标准(试行)[S].[S].中华人民共和国卫生部,2001.2..
  • 4Guzmán-Blanco,Mejía C,Isturiz R,et al.Epidemiology ofmethicillin-resistant Staphylococcus aureus(MRSA)in LatinAmerica[J].Int J Antimicrob Agents,2009,34(4):304-308.
  • 5李家泰,齐慧敏,李耘,代表中国细菌耐药监测研究组.2002—2003年中国医院和社区获得性感染革兰阳性细菌耐药监测研究[J].中华检验医学杂志,2005,28(3):254-265. 被引量:225
  • 6Yerino G A,Vazquez M S,Magneres C,et al.Characteriza-tion of community-acquired Staphylococcus aureus methicillin-resistant(CA-MRSA)vs methicillin susceptible Staphylococ-cus aureus(CA-MSSA)infection(Inf)in Argentinean children[J].Int J Infect Dis,2010,14(Supplement 1):396.
  • 7Huang Y C,Chen C J.Community-associated methicillin-re-sistant Staphylococcus aureus in children in Taiwan,2000s[J].Int J Antimicrob Agents,2011,38(1):2-8.
  • 8Kang C I,Song J H,Chung D R,et al.Risk factors andtreatment outcomes of community-onset bacteremia caused byextended-spectrum beta-lactamase-producing Escherichia coli[J].Int J Antimicrob Agents,2010,36(3):284-287.
  • 9Falagas M E,Karageorgopoulos D E.Extended-spectrumβ-lactamase-producing organisms[J].J Hosp Infect,2009,73(4):345-354.
  • 10Laupland K B,Church D L,Vidakovich J,et al.Communi-ty-onset extended-spectrumβ-lactamase(ESBL)producingEscherichia coli:Importance of international travel[J].J In-fect,2008,57(6):441-448.

二级参考文献11

  • 1National Committee for Clinical Laboratory Standard, 2002. Performance standards for antimicrobial susceptibility testing. Wayne.Pennsylvania:NCCLS, 2002.1- 50.
  • 2Jeijaszewicz J, Mlynarczyk G, Mlynarcqyk A. Antibiotic resistance in Gram-positive cocci. Int J Antimicrob Chemother, 2000,16:473-478.
  • 3Mutnick AH, Biedenbach DJ, Turnidge JD, et al. Spectrum and potency evaluation of a new oxazolidinone, linezolid:report from the SENTRY Antimicrobial Surveillance Program, 1998-2000. Diagn Microbiol Infect Dis, 2002,43:65-73.
  • 4Jones RN, Biedenbach DJ,Beach ML.Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America (2000-2001):report from the SENTRY Antimicrobial Surveillance Program. Diag Microbiol Infect Dis, 2003,46:77-80.
  • 5Biedenbach DJ, Stephen JM ,Jones RN. Antimicrobial susceptibility profile among β-haemolytic Streptococcus spp.collected in the SENTRY Antimicrobial Surveillance Program-North America, 2001. Diag Microbiol Infect Dis, 2003,46:291-294.
  • 6Biedenbach DJ, Jones RN. Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones:prevalence results from the SENTRY Antimicrobial Surveillance Program. Diag Microbiol Infect Dis, 2003,46:55-61.
  • 7Avanzini C, Bosio K, Volpe G, et al. Streptococcus pyogenes collected in Torino (northwest Italy) between 1983 and 1998:Survey of macrolide resistance and trend of genotype by RAPD. Microbial Drug Resistance, 2000,6:289-295.
  • 8Mutnick AH, Biedenbach DJ, Jones RN. Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997-2000). Diag Microbiol Infect Dis, 2003,46:63-68.
  • 9李家泰,AllanJ Weinstein,杨敏,中国细菌耐药监测研究组.中国细菌耐药监测研究[J].中华医学杂志,2001,81(1):8-16. 被引量:376
  • 10李家泰,高磊,薛峰,郝凤兰,王琪,蔡柏蔷,干春兰,刘又宁,余秉翔,何礼贤,胡必杰,陈雪华,郑经川,俞云松,吕芳芳,梁德荣,蔡永宁,康健,孔灵菲,肖正伦,郑劲平,刘杰,杨维兴,周泾.头孢妥仑匹酯对呼吸系统感染性疾病治疗的有效性和安全性[J].中华医学杂志,2003,83(5):391-394. 被引量:15

共引文献446

同被引文献170

引证文献29

二级引证文献151

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部